Skin Cancers Revisited
Sun Blocked
A new study examines non-melanoma skin cancers & HIV
by Chael Needle
In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated...
TAG’s Pipeline Report
Pipeline Report
Treatment Action Group provides updates on treatments for HIV, HCV & TB
by Hank Trout
Treatment Action Group (TAG) has announced the release of the...
Cuts to Healthcare
Treatment Horizons by Chael Needle
Hill & Mountain?
Weakened federal support of HIV/AIDS services puts our health at risk
President Obama’s fiscal year 2014 budget plan includes...
Expanded Portfolio
A new study reports on the drug-drug interaction between pitavastatin and a common PI combo
by Chael Needle
Last year, A&U reported on a study that...
Highest HIV Viral Suppression Rate in New Ryan White Program
Highest HIV Viral Suppression Rate in New Ryan White Program
In its fifth annual publication of national client-level data from the Ryan White HIV/AIDS Program...
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...
Optimal ARTs for Older Adults with HIV
Optimal ARTs for Older Adults with HIV
Recently, the HIV-Age.org website published the results of a review to identify the most effective, least toxic ART...
Global HIV and COVID-19 Emergency Response Fund
Global HIV and COVID-19 Emergency Response Fund
On April 27, 2020, ViiV Healthcare announced the creation of £3-million Global HIV and COVID-19 Emergency Response Fund...
Injection Breakthrough
Injection Breakthrough
FDA Approves a Complete Long-Actimng Injectable Regimen for HIV Treatment
by Hank Trout
On January 21, 2021, The U.S. Food and Drug Administration (FDA) approved...
LATEST POSTS
Ron B: Cover Story
“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...
